<?xml version="1.0" encoding="UTF-8"?>
<p id="Par11">New or re-purposed drugs are being explored for treatment of COVID19. Ongoing trials that are treating patients with doses as high as 1â€‰g daily of hydroxychloroquine (HCQ) for 10 days. However as retinal toxicity due to HCQ is dependent on cumulative dose and duration, the aforementioned doses are unlikely to cause retinal toxicity [
 <xref ref-type="bibr" rid="CR25">25</xref>].
</p>
